RGEN- Repligen Corporation
Repligen Corporation (RGEN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $15.78M | - | |
| Dir | 91.8K | $14.64M | - | |
| CEO | 54.2K | $8.65M | - | |
| VP | 20.1K | $3.20M | - | |
| Other | 8.5K | $1.36M | - |
Activity
Buys and sells only
Transactions
10 filings · page 6
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2021 | Ryan Thomas F Jr66 | Director | Sell | 780 | $250.50 | $195,390.00 | -44.5% | +19.9% | -3.7% | |
| Jul 20, 2021 | Dawes Karen A63 | Director | Sell | 4,585 | $202.09 | $926,604.97 | -1.0% | +30.0% | -12.9% | |
| Jul 13, 2021 | Dawes Karen A63 | Director | Sale+OE | 1,520 | $202.23 | $307,389.60 | -1.3% | +26.3% | -17.5% | |
| Jun 10, 2021 | Kuriyel Ralf72 | Senior VP, R&D | Sale+OE | 6,802 | $189.19 | $1,286,870.38 | -24.2% | +54.9% | -21.5% | |
| May 19, 2021 | Hunt Anthony75 | Chief Executive Officer | Sell | 22,267 | $171.41 | $3,816,697.92 | -1.4% | +45.8% | -12.3% | |
| May 14, 2021 | Gebski Christine62 | See Remarks | Sell | 445 | $172.25 | $76,651.25 | -1.2% | +48.4% | -12.5% | |
| May 14, 2021 | Kuriyel Ralf72 | Senior VP, R&D | Sell | 710 | $172.29 | $122,325.90 | -2.8% | +48.4% | -12.5% | |
| May 14, 2021 | Snodgres Jon59 | Chief Financial Officer | Sell | 470 | $172.60 | $81,122.00 | -1.5% | +48.4% | -12.5% | |
| May 11, 2021 | Dawes Karen A63 | Director | Sale+OE | 285 | $176.85 | $50,402.25 | -0.2% | +45.6% | -19.1% | |
| Apr 6, 2021 | Bylund James70 | SVP, Global Operations &It | Sell | 360 | $204.25 | $73,530.00 | -5.4% | -0.4% | -13.2% |